For: | Madir A, Grgurevic I, Tsochatzis EA, Pinzani M. Portal hypertension in patients with nonalcoholic fatty liver disease: Current knowledge and challenges. World J Gastroenterol 2024; 30(4): 290-307 [PMID: 38313235 DOI: 10.3748/wjg.v30.i4.290] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i4/290.htm |
Number | Citing Articles |
1 |
Francesca Schinzari, Manfredi Tesauro, Carmine Cardillo. Is endothelin targeting finally ready for prime time?. Clinical Science 2024; 138(11): 635 doi: 10.1042/CS20240607
|
2 |
Anja M. Fischer, Nazim Lechea, Harvey O. Coxson. This Is What Metabolic Dysfunction–Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol. Seminars in Liver Disease 2024; 44(02): 226 doi: 10.1055/a-2334-8525
|
3 |
Yifan Lv, Bing Zhu, Dongze Li, Hua Tian, Shaoli You, Sa Lv, Fuchuan Wang, Yongping Yang, Huiguo Ding, Yifan Wu, Chengbin Dong, Yu Zhang, Fuquan Liu. Stratified analysis of the correlation between wedged hepatic venous pressure and portal venous pressure in patients with portal hypertension. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-80870-9
|
4 |
Halima Righi, Fadia Bekhti-Sari, Sabri Ahmed Cherrak, Reda Bettioui, Dahbia Ines Dahmani, Ouarda Sariyah Ayachi, Bachir Bensenane, Ahmed Belloufa, Hafida Merzouk, Nassima Amal Mokhtari-Soulimane. Elucidating the effect of camel α-lactalbumin in modulating obesity-related metabolic disorders in an obese rat model. International Journal of Biological Macromolecules 2025; 295: 139693 doi: 10.1016/j.ijbiomac.2025.139693
|
5 |
Sahib Singh, Saurabh Chandan, Sumant Inamdar, Kambiz S. Kadkhodayan, Jahnvi Dhar, Jayanta Samanta, Antonio Facciorusso. EUS-Guided Vascular Interventions: Recent Advances. Journal of Clinical Medicine 2024; 13(16): 4835 doi: 10.3390/jcm13164835
|
6 |
Tamer A. Addissouky. Liver stiffness as a dynamic predictor of decompensation and mortality in alcohol-related liver disease. Discover Medicine 2024; 1(1) doi: 10.1007/s44337-024-00083-x
|